EP1993606A4 - Immunoglobulins from vitiligo plasma for melanoma therapy - Google Patents
Immunoglobulins from vitiligo plasma for melanoma therapyInfo
- Publication number
- EP1993606A4 EP1993606A4 EP07794323A EP07794323A EP1993606A4 EP 1993606 A4 EP1993606 A4 EP 1993606A4 EP 07794323 A EP07794323 A EP 07794323A EP 07794323 A EP07794323 A EP 07794323A EP 1993606 A4 EP1993606 A4 EP 1993606A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- vitiligo
- immunoglobulins
- plasma
- melanoma therapy
- melanoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77331906P | 2006-02-15 | 2006-02-15 | |
PCT/US2007/003918 WO2007117356A2 (en) | 2006-02-15 | 2007-02-15 | Immunoglobulins from vitiligo plasma for melanoma therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1993606A2 EP1993606A2 (en) | 2008-11-26 |
EP1993606A4 true EP1993606A4 (en) | 2010-01-20 |
Family
ID=38581540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07794323A Withdrawn EP1993606A4 (en) | 2006-02-15 | 2007-02-15 | Immunoglobulins from vitiligo plasma for melanoma therapy |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1993606A4 (en) |
AU (1) | AU2007237163A1 (en) |
CA (1) | CA2642632A1 (en) |
WO (1) | WO2007117356A2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997045744A1 (en) * | 1996-05-28 | 1997-12-04 | University Of British Columbia | Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994269A (en) * | 1989-03-17 | 1991-02-19 | Miles Inc. | Topical use of antibodies for prevention or treatment of pseudomonas infections |
US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
US6685940B2 (en) * | 1995-07-27 | 2004-02-03 | Genentech, Inc. | Protein formulation |
EP1750683B1 (en) * | 2004-04-23 | 2013-01-09 | Amgen Inc. | Sustained release formulations |
-
2007
- 2007-02-15 AU AU2007237163A patent/AU2007237163A1/en not_active Abandoned
- 2007-02-15 WO PCT/US2007/003918 patent/WO2007117356A2/en active Application Filing
- 2007-02-15 EP EP07794323A patent/EP1993606A4/en not_active Withdrawn
- 2007-02-15 CA CA002642632A patent/CA2642632A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997045744A1 (en) * | 1996-05-28 | 1997-12-04 | University Of British Columbia | Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
Non-Patent Citations (5)
Title |
---|
BAR-DAYAN Y ET AL: "ANTIBODIES TO THE CYTOPLASM, CELL MEMBRANE AND NUCLEAR MEMBRANE OF MALIGNANT NEOPLASMS IN POOLED NORMAL HUMAN POLYSPECIFIC IMMUNOGLOBULIN G", INTERNATIONAL JOURNAL OF ONCOLOGY, DEMETRIOS A. SPANDIDOS ED. & PUB, GR, vol. 15, no. 6, 1 December 1999 (1999-12-01), pages 1091 - 1096, XP009011084, ISSN: 1019-6439 * |
FISHMAN P ET AL: "AUTOIMMUNITY AND CANCER - BENEFICIAL RELATIONSHIPS: A NEW CONCEPT FOR THE PRODUCTION OF HUMAN MONOCLONAL ANTIBODIES (REVIEW)", INTERNATIONAL JOURNAL OF ONCOLOGY, DEMETRIOS A. SPANDIDOS ED. & PUB, GR, vol. 10, no. 5, 1 May 1997 (1997-05-01), pages 901 - 904, XP000867200, ISSN: 1019-6439 * |
FISHMAN P ET AL: "Vitiligo autoantibodies are effective against melanoma.", CANCER 15 OCT 1993, vol. 72, no. 8, 15 October 1993 (1993-10-15), pages 2365 - 2369, XP002559449, ISSN: 0008-543X * |
KUHN A ET AL: "1st International Conference on Cutaneous Lupus Erythematosus Dusseldorf, Germany, September 1-5, 2004", AUTOIMMUNITY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 4, no. 1, 1 January 2005 (2005-01-01), pages 66 - 78, XP004713811, ISSN: 1568-9972 * |
SHOENFELD Y ET AL: "Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment.", THE ISRAEL MEDICAL ASSOCIATION JOURNAL : IMAJ SEP 2001, vol. 3, no. 9, September 2001 (2001-09-01), pages 698 - 699, XP002559450, ISSN: 1565-1088 * |
Also Published As
Publication number | Publication date |
---|---|
CA2642632A1 (en) | 2007-10-18 |
WO2007117356A3 (en) | 2008-01-31 |
AU2007237163A1 (en) | 2007-10-18 |
WO2007117356A2 (en) | 2007-10-18 |
EP1993606A2 (en) | 2008-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2069047A4 (en) | Plasma reactor | |
GB0712494D0 (en) | Substrate reduction therapy | |
EP2123136A4 (en) | Improved plasma source | |
HK1142844A1 (en) | Showerhead | |
GB0610680D0 (en) | Therapeutic compounds | |
GB0603041D0 (en) | Therapeutic compounds | |
GB2461816B (en) | Plasma treatment apparatus | |
IL197389A0 (en) | Prophylactic or therapeutic agent for cancer | |
EP2035369A4 (en) | Therapeutic compounds | |
GB0606663D0 (en) | Therapeutic compounds | |
HUE038611T2 (en) | Therapy for vitiligo | |
GB0615809D0 (en) | Therapeutic compounds | |
GB0612971D0 (en) | Therapeutic compounds | |
EP2018873A4 (en) | Prophylactic/therapeutic agent for cancer | |
EP2079704A4 (en) | Therapeutic compounds | |
GB2467671B (en) | Plasma deposition apparatus | |
GB0605573D0 (en) | Therapeutic Compounds | |
GB0603455D0 (en) | Therapeutic compounds | |
EP1993606A4 (en) | Immunoglobulins from vitiligo plasma for melanoma therapy | |
GB0608269D0 (en) | Therapeutic compounds | |
GB2441499B (en) | Slimming Spray | |
GB0613584D0 (en) | Therapeutic compounds | |
HU0700326D0 (en) | Plasma throner | |
AU2007900499A0 (en) | Therapy for vitiligo | |
IL178522A (en) | Combined plasma source |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080915 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/395 20060101ALI20091210BHEP Ipc: A61K 35/16 20060101ALI20091210BHEP Ipc: C07K 16/06 20060101AFI20091210BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20091218 |
|
17Q | First examination report despatched |
Effective date: 20100409 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100820 |